Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Epix Pharmaceuticals, Inc. (EPIX) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Epix Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1027702.
Total stock buying since 2006: $0.
Total stock sales since 2006: $0.
Total stock option exercises since 2006: $104,068.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 0 | $0 | 0 | $0 | 17,500 | $0 |
| 2007 | 0 | $0 | 0 | $0 | 50,521 | $49,510 |
| 2006 | 0 | $0 | 0 | $0 | 55,672 | $54,558 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-02 | 0 | $0 | 0 | $0 | 17,500 | $0 |
| 2007-01 | 0 | $0 | 0 | $0 | 50,521 | $49,510 |
| 2006-11 | 0 | $0 | 0 | $0 | 55,672 | $54,558 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-02-25 | Drapkin Kimberlee C (Chief Financial Officer) | Option Ex | 8,750 | .00 | 0 |
| 2009-02-25 | Schor Chen (Chief Business Officer) | Option Ex | 8,750 | .00 | 0 |
| 2007-01-03 | Kauffman Michael G (Chief Executive Officer) | Option Ex | 50,521 | .98 | 49,510 |
| 2006-11-28 | Schor Chen (Chief Business Officer) | Option Ex | 3,000 | .98 | 2,940 |
| 2006-11-06 | Drapkin Kimberlee C (Chief Financial Officer) | Option Ex | 11,000 | .98 | 10,780 |
| 2006-11-03 | Kauffman Michael G (Chief Executive Officer) | Option Ex | 26,672 | .98 | 26,138 |
| 2006-11-02 | Schor Chen (Chief Business Officer) | Option Ex | 15,000 | .98 | 14,700 |
Insider trading activities including stock purchases, stock sales, and option exercises of EPIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Epix Pharmaceuticals, Inc. (symbol EPIX, CIK number 1027702) see the Securities and Exchange Commission (SEC) website.